Physician profile
George E Thomas
NPI 1891101887
$2,983.40
in general payments reported to CMS, 2019-2025
27 companies · $1,695 in 2025
The $1,695 reported for 2025 was more than what 94% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $96.45 · 2020: $17.71 · 2021: $343 · 2022: $346 · 2023: $210 · 2024: $276 · 2025: $1,695.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $1,347 · Food and Beverage: $764 · Education: $69.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $1,347.00 |
| Food and Beverage | $763.79 |
| Education | $69.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Masimo Corporation | $909.00 | 2025 | |
| Abbvie INC. | $488.91 | 2021-2023 | Ubrelvy |
| Stryker Corporation | $413.00 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $241.05 | 2019-2025 | |
| Exeltis, USA INC. | $132.68 | 2021-2025 | Slynd |
| Mayne Pharma Commercial LLC | $104.65 | 2022-2025 | |
| Astellas Pharma US INC | $96.27 | 2024-2025 | Veozah |
| Genentech, INC. | $91.52 | 2025 | Tecentriq |
| Organon LLC | $70.78 | 2022-2024 | |
| Myovant Sciences INC. | $57.35 | 2022 | |
| Medtronic, INC. | $54.84 | 2022-2025 | Closurefast |
| Hologic Sales and Service, LLC | $49.54 | 2023-2024 | Aptima, Thinprep 2000 Processor |
| Minerva Surgical, INC | $35.72 | 2023 | |
| Teleflex LLC | $35.38 | 2025 | Quikclot |
| Millicent US INC | $22.33 | 2025 | Femlyv |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shield Therapeutics INC | $21.46 | 2024 | |
| Boston Scientific Corporation | $17.99 | 2024 | Advantage System |
| Daiichi Sankyo INC. | $17.71 | 2020 | |
| Innovation Technologies INC | $16.03 | 2025 | Irrisept |
| Agile Therapeutics, INC. | $14.74 | 2024 | Twirla |
| Sage Therapeutics, LLC | $14.56 | 2025 | Zurzuvae |
| Supernus Pharmaceuticals, INC. | $14.56 | 2025 | Qelbree |
| Merck Sharp & Dohme LLC | $14.37 | 2023 | Gardasil 9 |
| Gynesonics, INC. | $13.75 | 2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Convatec INC. | $13.23 | 2023 | |
| Avanos Medical | $11.77 | 2022 | |
| Channel Medsystems, INC. | $10.21 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw George Thomas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.